✨ Your Portfolio is fetched and updated from zerodha.
Small Pharmaceuticals

Senores Pharmaceuticals Ltd.

SENORES

Get real time AI alerts about this company on your WhatsApp!
Market Cap
₹3,196 Cr.
P/E
54.57

Senores Pharmaceuticals Ltd.

  • Senores Pharmaceutic
  • Ajanta Pharma
  • Alembic Pharma

FAQs on Senores Pharmaceuticals Ltd. Shareprice

There is not enough historical data for the companies share price.

Senores Pharmaceutic is expensive when considering the EV/EBIDTA, however latest PE is < 3 yr avg PE.
Latest PE of Senores Pharmaceutic is 54.57, while 3 year average PE is 82.76.
Also latest EV/EBITDA of Senores Pharmaceutic is 30.96 while 3yr average is 30.22.

View FAQ's On Business

Growth Table

  • Senores Pharmaceuticals Ltd.
  • Ajanta Pharma
  • Alembic Pharma

Balance Sheet

  • Senores Pharmaceuticals Ltd.
  • Ajanta Pharma
  • Alembic Pharma

Balance Sheet Snapshot

No data available.

Fund Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end

Profit & Loss

  • Senores Pharmaceuticals Ltd.
  • Ajanta Pharma
  • Alembic Pharma

Cash Flow

  • Senores Pharmaceuticals Ltd.
  • Ajanta Pharma
  • Alembic Pharma

Cash Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.

Ratios

= Dominant Factor
  • Senores Pharmaceuticals Ltd.
  • Ajanta Pharma
  • Alembic Pharma

Quarterly Results

  • Senores Pharmaceuticals Ltd.
  • Ajanta Pharma
  • Alembic Pharma

Reverse DCF

locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Raphson method.
Learn how to use Reverse DCF

FAQs on Senores Pharmaceuticals Ltd. Financials

Balance sheet of Senores Pharmaceutic is strong.
It shouldn't have solvency or liquidity issues.

The net debt of Senores Pharmaceutic is decreasing.
Latest net debt of Senores Pharmaceutic is -₹465.94 Crs as of Mar-25.
This is less than Mar-24 when it was ₹222 Crs.

Yes, profit is increasing.
The profit of Senores Pharmaceutic is ₹66.49 Crs for TTM, ₹58.56 Crs for Mar 2025 and ₹31.46 Crs for Mar 2024.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Senores Pharmaceutic latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

Companies resources are allocated to majorly unproductive assets like Cash & Short Term Investments

View FAQ's On Shareholding
Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech